
Michelle Dalton, ELS
Advertisement
Articles by Michelle Dalton, ELS








This year’s ASRS PAT survey show subtle regional differences

The ASRS Global Trends Survey finds differences in some treatment preferences


Group of researchers aim to validate both approaches in proof-of-concept study







Fifteen fellows, residents showed just why research in retina is on the cutting edge









Research finds limited publications and dearth of information about side effects

Findings from the PERMEATE study used novel diagnostics to quantify response to intravitreal injections


When used one week after injection, optical coherence tomography angiography can help clinicians determine how effective their treatment has been on neovascular membrane reperfusion.
Advertisement
Advertisement
Advertisement
Trending on Modern Retina
1
Q&A: Evolving approaches to geographic atrophy management
2
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
3
Exploring Emerging Therapies in the Retinal Vascular Disease Pipeline
4
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
5